SecBot SecBot
Institutional Cluster

MDGL

MADRIGAL PHARMACEUTICALS, INC.
MIXED
Impact 3/10
Horizonweeks Processed11d 10h ago
Institutional cluster: 5 buyers, 5 sellers (mixed)
Actionable Insight ◆ Mixed

The mixed cluster with net selling bias and zero insider buying suggests institutions are divided on MDGL after the strong Q3 earnings. Monitor next 13F filings and insider transaction patterns for confirmation of the thesis shift.

DirectionMixed
Confidencemedium
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$400.10
T+0 close · Nov 5, 2026 · via day close
Latest settled
+6.28%
T+5 · $425.21
Vs SPY
+2.99%
α at T+5
Next horizon
T+20
in 17d
  1. T+0 · Nov 5 $400.10entry
  2. T+1 · 11d ago −0.12%α −0.43% · $399.63
  3. T+5 · 5d ago +6.28%α +2.99% · $425.21
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Q3 2026 13F filings for Madrigal Pharmaceuticals show a mixed institutional cluster: 5 buyers added $50.1M in new holdings (led by Citigroup doubling its stake to $62M), while 5 sellers reduced positions by $71.2M (led by Assenagon Asset Management exiting 83% of its stake, selling $56.2M). The cluster follows the company's first profitable quarter (Q3 2026 net income of $55.4M, revenue $431.3M, Rezdiffra achieving blockbuster status), but the net selling bias and lack of insider buying (confluence score 21/100) suggest mixed conviction among institutions.

Key Financial Metrics

Direction
mixed
Buy Value
$78.4M
Sell Value
$71.2M
Net Flow
-$21.1M

Institutional Positions

Net institutional flow: -$21.1M

▲ Buyers (5)

InstitutionActionChangePosition ValueValue Δ
CitigroupDOUBLED+230.3%$62.0M$42.0M
Wealth Enhancement Advisory ServicesDOUBLED+1111.7%$3.1M$2.8M
Creative PlanningADD+70.8%$11.3M$4.3M
Calamos AdvisorsADD+83.3%$1.5M$635.0K
Farther Finance AdvisorsDOUBLED+713.2%$434.0K$378.0K

▼ Sellers (5)

InstitutionActionChangePrev ValueValue Δ
Assenagon Asset ManagementNEAR_EXIT-83.3%$66.7M-$56.2M
Allspring Global Investments HoldingsTRIM-34.9%$34.8M-$12.8M
Imc-ChicagoTRIM-30%$5.8M-$2.0M
Strs OhioTRIM-34.9%$203.0K-$79.0K
Nisa Investment AdvisorsTRIM-53.9%$186.0K-$106.0K

Key Facts

  • 5 institutional buyers added $50.1M in new positions during Q3 2026
  • 5 institutional sellers reduced positions by $71.2M during the same quarter
  • Citigroup doubled its stake to $62.0M (largest buyer by value)
  • Assenagon Asset Management executed a near-exit, selling $56.2M (largest seller by value)
  • No open-market insider buying was detected (confluence score 21/100, divergent)
  • Q3 2026 earnings (filed 2 days prior) showed first profitable quarter: net income $55.4M, revenue $431.3M (+50% YoY)

Financial Impact

Net institutional selling of $21.1M ($50.1M buying vs $71.2M selling) across 10 funds; largest single move was Assenagon's $56.2M reduction

institutional ownershipfloat

Risk Factors

  • 13F data is 45+ days stale; positions may have been unwound since quarter-end
  • No insider buying to corroborate institutional accumulation
  • Net selling bias despite strong earnings may indicate profit-taking or valuation concerns

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (26 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-MDGL-2026-Q3

Track record

18 reports on MDGL

Performance horizon

3 of 6 bullish or bearish reports moved the stock their way by T+5. Best: +10.26% at T+20 after the Jul 30, 2026 report. 3 of 6 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry price pending
  2. Nov 6, 202610d ago SC 13D/A Neutral 3/10 Entry $432.79 to $423.96 ▼ −2.04% −0.35% vs SPY
  3. Nov 6, 202610d ago Insider Buy Bullish 5/10 Entry $432.79 to $423.96 ▼ −2.04% −0.35% vs SPY
  4. Nov 6, 202610d ago Insider Cluster Bullish 5/10 Entry $432.79 to $423.96 ▼ −2.04% −0.35% vs SPY
  5. Nov 6, 202610d ago 144 Neutral 2/10 Entry $432.79 to $423.96 ▼ −2.04% −0.35% vs SPY
  6. Nov 5, 202611d ago Institutional Cluster Mixed 3/10 Viewing Entry $400.10 to $425.21 ▲ +6.28% +2.99% vs SPY
  7. Nov 5, 202611d ago Press Release Bullish 5/10 Entry $400.10 to $425.21 ▲ +6.28% +2.99% vs SPY
  8. Nov 3, 202613d ago 8-K Bullish 7/10 No price data
  9. Nov 3, 202613d ago Press Release Bullish 6/10 Entry $396.32 to $432.60 ▲ +9.15% +9.74% vs SPY
  10. Aug 12, 202613w ago 8-K Neutral 3/10 Entry $536.20 to $540.16 ▲ +0.74% +1.18% vs SPY
Showing 10 of 18

US Market Status

Market Closed · Opens Wed (9h 50m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026